3/10
04:36 pm
crnx
Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/1
07:36 am
crnx
Crinetics Pharmaceuticals (NASDAQ:CRNX) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
Medium
Report
Crinetics Pharmaceuticals (NASDAQ:CRNX) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
2/27
05:49 pm
crnx
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
2/27
04:05 pm
crnx
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Medium
Report
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
2/27
04:01 pm
crnx
Is Crinetics Pharmaceuticals (CRNX) the Worst Performing Mid Cap Stock to Buy According to Analysts? [Yahoo! Finance]
Medium
Report
Is Crinetics Pharmaceuticals (CRNX) the Worst Performing Mid Cap Stock to Buy According to Analysts? [Yahoo! Finance]
2/24
08:41 am
crnx
Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer [Yahoo! Finance]
Medium
Report
Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer [Yahoo! Finance]
2/24
08:30 am
crnx
Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer
Medium
Report
Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer
2/20
04:05 pm
crnx
Crinetics Pharmaceuticals to Participate in Two Upcoming March Investor Conferences
Low
Report
Crinetics Pharmaceuticals to Participate in Two Upcoming March Investor Conferences
2/11
07:26 am
crnx
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
Medium
Report
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
2/10
05:50 pm
crnx
Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
2/10
04:44 pm
crnx
Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/6
05:45 pm
crnx
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 [Yahoo! Finance]
Medium
Report
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 [Yahoo! Finance]
2/6
04:35 pm
crnx
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
Medium
Report
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
2/4
08:22 am
crnx
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
Medium
Report
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
1/22
07:39 am
crnx
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $55.00 price target on the stock.
Medium
Report
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $55.00 price target on the stock.
1/13
08:04 am
crnx
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $81.00 price target on the stock.
Medium
Report
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $81.00 price target on the stock.
1/11
03:58 pm
crnx
Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
1/10
05:15 pm
crnx
Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/10
07:00 am
crnx
Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)
High
Report
Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)
1/6
12:21 pm
crnx
Crinetics Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Crinetics Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/6
08:00 am
crnx
Crinetics Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Medium
Report
Crinetics Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
12/16
09:50 am
crnx
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $87.00 price target on the stock.
Low
Report
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $87.00 price target on the stock.
12/16
08:07 am
crnx
Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer [Yahoo! Finance]
Low
Report
Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer [Yahoo! Finance]
12/16
08:00 am
crnx
Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer
Low
Report
Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer